CUAMC
ACET icon

China Universal Asset Management Company’s Adicet Bio ACET Stock Holding History

China Universal Asset Management Company’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-69
Closed -$1.51K – 428
2023
Q3 		$1.51K Buy
69
+34
+97% +$1.2K ﹤0.01% 441
2023
Q2 		$1.37K Sell
35
-1
-3% -$88 ﹤0.01% 444
2023
Q1 		$3.35K Buy
36
+9
+33% +$1.13K ﹤0.01% 407
2022
Q4 		$3.89K Buy
27
+4
+17% +$998 ﹤0.01% 325
2022
Q3 		$5K Buy
+23
New +$5.84K ﹤0.01% 265

Other funds holding ACET

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

China Universal Asset Management Company's ACET Position: Q4 2023 in Review

China Universal Asset Management Company sold out of Adicet Bio (ACET) in Q4 2023, closing a stake of 69 shares — an estimated $1.51K sold.

China Universal Asset Management Company first reported a position in ACET in Q3 2022 and held it in 5 quarters. The position peaked at $5K in Q3 2022. 76 funds tracked by Wall St. Rank hold ACET as of Q4 2023.

  • China Universal Asset Management Company reported no remaining Adicet Bio position as of Q4 2023 after selling out during the quarter.
  • China Universal Asset Management Company sold 69 Adicet Bio shares in Q4 2023, an estimated $1.51K.
  • China Universal Asset Management Company first reported a position in Adicet Bio in Q3 2022 and held it in 5 quarters.
  • China Universal Asset Management Company's Adicet Bio position peaked at $5K in Q3 2022.
  • 76 funds tracked by Wall St. Rank held Adicet Bio as of Q4 2023.

Based on China Universal Asset Management Company's 13F filing for Q4 2023, filed 24 Jan 2024.